fda warning letter semaglutide october 2025 The sent a this month to Novo Nordisk, alleging the drugmaker failed to report, in a timely manner, potential side effects in patients who took its popular medications containing Hims and Hers warns investors

Metformin, lifestyle intervention, and cognition in the diabetes prevention program outcomes study

The body cannot produce omega-3s on its own, which is why we must obtain them from our diet

Bismah Irfan, MD As of May 2026, retatrutide is not yet FDA-approved

What Form of Carnitine Might Work Best for Health-Related Purposes

Give semaglutide at least 16 weeks at your target therapeutic dose before concluding that it is insufficient

Aligned with this need, recently, the Ministry of Health in Indonesia established an initiative to provide support for DM management through the Diabetes Center program, which involves a team of professionals providing comprehensive diabetes care, from large hospitals to hospitals in districts